Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Conditions:   Dysentery;   Shigellosis Interventions:   Biological: S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine;   Biological: Placebo Sponsor:   Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Not yet recruiting

Source: ClinicalTrials.gov - December 14, 2021 Category: Research Source Type: clinical trials